On June 5, 2026, WuXi Biologics marked a major milestone at its Singapore manufacturing site with the successful topping-out of all the main modules of its new modular drug product (DP) facility, a project in collaboration with Pharmadule Morimatsu. This achievement lays a strong foundation for the ongoing construction and delivery of the project.
Through deep integration of off-site prefabrication and on-site modular assembly, Pharmadule Morimatsu efficiently completed core design, supply chain integration, and module manufacturing within a compact timeframe. This significantly shortened construction cycle compared with the traditional construction method, fully demonstrating the distinct advantages of the modular construction model.
As a global professional provider of modular solutions, Pharmadule Morimatsu leverages flexible modular design to accommodate diversified products and dosage forms. Supported by dedicated quality control and manufacturing science labs precisely aligned with construction and production capacity, the facility establishes an integrated manufacturing system spanning the entire value chain, providing efficient and reliable support for the commercial production of biologics.
Mr.Daoquan Li, CEO of Morimatsu Pharmadule(China) stated：“Pharmadule Morimatsu has achieved the topping out with highly efficient and flexible modular construction method. Through rigorous project management and technical oversight, we will further assist WuXi Biologics in building its advanced biologics CRDMO hub, ensuring consistent quality and reliability, and working together to contribute to the development of the pharmaceutical industry."
About Morimatsu LifeSciences
Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.
Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.
Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.
Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.
As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.
About Pharmadule Morimatsu
Since its establishment in 1986, Pharmadule(a member of Morimatsu Group since 2011) has delivered more than 90 production facilities in pharma and biopharma industries globally as well as completed more than 300 engineering designs and solution validations which demonstrates us as the integrated, holistic facility as well as core process equipment leading provider in the world.
